Prevalence and Incidence of Problematic Prescription Opioid Use and Abuse in the United Kingdom and Germany (OXY9504)

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Assessment of risk minimisation measure implementation or effectiveness

  Drug utilisation
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Anatomical Therapeutic Chemical (ATC) code:
  (N02A) OPIOIDS

  OPIOIDS
• Medical condition to be studied:
  Drug abuse

Population studied

• Short description of the study population:
  Patients with opioids use in the UK and Germany.
• Age groups:
  Infants and toddlers (28 days – 23 months)

  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  180000

Study design details

• Main study objective:
  Quantify problematic prescription use and abuse of prescription opioids in Germany and the United Kingdom
• Outcomes:
  Incidence and 5-year prevalence of problematic prescription use and abuse of prescription opioids from 2008-2012, Characterisation of the abusing and non-abusing population: demographics, drug utilisation.
• Data analysis plan:
  Calculation of incidence rate and 5-year prevalence of problematic use of prescription opioids per molecule from 2008 to 2012.